Expand Content

Gabriel Léger, MD


Gabriel  Léger, MD

Appointed: 2011

Gabriel Léger, MD
Department: Cleveland Clinic Lou Ruvo Center for Brain Health
Associate Staff
Location: Lou Ruvo Center for Brain Health
Mail Code Las Vegas
888 W. Bonneville
Las Vegas, NV 89106
Type of Doctor:
Adults Only

Biographical Sketch

Doctor Léger was appointed to the Alzheimer’s Disease Program, Lou Ruvo Center for Brain Health in October 2011. He completed his training in clinical neurology at the Montreal Neurological Institute, where he also performed research in imaging of neurodegenerative diseases. He completed a clinical fellowship in cognitive and behavioral neurology at Northwestern University. Committed to patient care and clinical research, he is also dedicated to medical education. Before coming to the Cleveland Clinic, he was Assistant Professor and Director of the Neurology Residency program at the University of Montreal. He has participated in a number of clinical trials in the diagnosis and treatment of Alzheimer’s disease. In addition, he has special interests and expertise in the diagnosis and treatment of atypical or focal dementias, including frontotemporal dementia (FTD or Pick’s disease), Primary Progressive Aphasia, Posterior Cortical Atrophy, and dementias with Lewy bodies, which include the Parkinson’s Disease Dementia.

Education & Fellowships

Fellowship - Northwestern University Affiliated Hospitals
Cognitive Behavioral Neurology
Chicago, IL USA
Fellowship - Montreal Neurological Institute and Hospital
Movement Disorders
Montreal, Quebec Canada
Residency - Montreal Neurological Institute and Hospital
Montreal, Quebec Canada
Medical School - McGill University Faculty of Medicine
Montreal, Quebec Canada
Undergraduate - McGill University
Montreal, Quebec Canada


  • Royal College of Physicians & Surgeons of Canada- Medicine

Treatment & Services

  • Cognitive/neuropsychological Evaluations

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/2/2014, Dr. Léger has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • French